leisure time -WSS

leisure time

author：focus 2025-09-06 04:41:12 - browse：458

BARCELONA, Spain — Some of the patients waiting in the oncology ward of a hospital here, with its green-tiled floor and white walls, had arrived for a newfangled remedy for blood cancers, what’s known as a CAR-T therapy.

The patients were not here for one of the brand-name medicines — a Kymriah or Yescarta — that have shown the power of these cell-based approaches and helped reap their makers hundreds of millions of dollars. Rather, they would be receiving a CAR-T brewed up right here at Hospital Clínic de Barcelona.

Under a special European policy, the CAR-T developed by the hospital’s experts had won regulatory approval in Spain and was reimbursed by the national health system like other authorized medications. The therapy provided another option for patients, all at a price of 89,000 euros ($97,000), roughly a third of the list prices of the CAR-T products from biopharma companies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： What we know about the American soldier detained in North Korea

entertainment

WSS

What the US credit downgrade means for the economy, your finances

‘Oppenheimer’ and the risks of AI in health care

Biden administration sends mixed signals on US soldier who crossed into North Korea

Robert Kennedy Jr.'s presidential campaign attracts GOP

UK homeowners get some respite as inflation falls by more than anticipated to a 15

Breakthrough Alzheimer’s drugs are inaccessible in rural states

hotspot

leisure time

focus

Continuity nursing helped my family in our darkest PICU moments

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Alkermes shareholders re

Idaho college killings: Prosecutors dispute DNA could have been planted at murder scene

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

More hospitals are billing patients as online messages surge

Wildfire smoke exposes gaps in outdoor worker protections

What the airline industry can learn from medicine

Dobbs anniversary: the lost opportunity of abortion as health care

Johnson & Johnson sues to stop Medicare negotiation

knowledge

Lack of darker skin in textbooks, journals harms patients of color

‘Oppenheimer’ and the risks of AI in health care

Study: Hearing aids may slow cognitive decline in those at risk

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

NIH launches clinical trials and new research office for long Covid

hotspot

entertainment

leisure time

explore